Cargando…

SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion

BACKGROUND: Metastatic prostate cancer (mPCa) has a poor prognosis with limited treatment options. The high mobility of tumor cells is the key driving characteristic of metastasis. However, the mechanism is complex and far from clarified in PCa. Therefore, it is essential to explore the mechanism of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zean, Tao, Yiran, Gao, Ze, Peng, Shirong, Lai, Yiming, Li, Kaiwen, Chen, Xu, Huang, Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161564/ https://www.ncbi.nlm.nih.gov/pubmed/37147713 http://dx.doi.org/10.1186/s12967-023-04146-y

Ejemplares similares

Immune Cytolytic Activity as an Indicator of Immune Checkpoint Inhibitors Treatment for Prostate Cancer
por: Gao, Ze, et al.
Publicado: (2020)

Pædiatric Pseudopodia
por: Craig, W. S.
Publicado: (1953)

Topoisomerase II-binding protein 1 promotes the progression of prostate cancer via ATR-CHK1 signaling pathway
por: Li, Kaiwen, et al.
Publicado: (2020)

The metastatic promoter DEPDC1B induces epithelial‐mesenchymal transition and promotes prostate cancer cell proliferation via Rac1‐PAK1 signaling
por: Li, Zean, et al.
Publicado: (2020)

Liquid metal amoeba with spontaneous pseudopodia formation and motion capability
por: Hu, Liang, et al.
Publicado: (2017)

Translocation or just location? Pseudopodia affect fluorescent signals
por: Dewitt, Sharon, et al.
Publicado: (2009)

The Ordered Extension of Pseudopodia by Amoeboid Cells in the Absence of External Cues
por: Bosgraaf, Leonard, et al.
Publicado: (2009)

SOX2 Promotes Brain Metastasis of Breast Cancer by Upregulating the Expression of FSCN1 and HBEGF
por: Xiao, Weikai, et al.
Publicado: (2020)

SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer
por: Liu, Xi-Yu, et al.
Publicado: (2020)

Formin homology domains of Daam1 bind to Fascin and collaboratively promote pseudopodia formation and cell migration in breast cancer
por: Hao, Leiyu, et al.
Publicado: (2021)

LincRNA-ROR promotes metastasis and invasion of esophageal squamous cell carcinoma by regulating miR-145/FSCN1
por: Shang, Muhe, et al.
Publicado: (2018)

SALL4 correlates with proliferation, metastasis, and poor prognosis in prostate cancer by affecting MAPK pathway
por: Zhou, Jie, et al.
Publicado: (2023)

High Functioning Autism with Missense Mutations in Synaptotagmin-Like Protein 4 (SYTL4) and Transmembrane Protein 187 (TMEM187) Genes: SYTL4- Protein Modeling, Protein-Protein Interaction, Expression Profiling and MicroRNA Studies
por: Rafi, Syed K., et al.
Publicado: (2019)

A Model for a Correlated Random Walk Based on the Ordered Extension of Pseudopodia
por: Van Haastert, Peter J. M.
Publicado: (2010)

Proteomic profiling of human cancer pseudopodia for the identification of anti-metastatic drug candidates
por: Choi, Sunkyu, et al.
Publicado: (2018)

Uncovering hidden structures: previously undescribed pseudopodia and ectoplasmic structures in planktonic foraminifera
por: Greco, Mattia, et al.
Publicado: (2023)

The Effects of Swiprosin-1 on the Formation of Pseudopodia-Like Structures and β-Adrenoceptor Coupling in Cultured Adult Rat Ventricular Cardiomyocytes
por: Nippert, Franziska, et al.
Publicado: (2016)

Prognostic significance of FSCN family in multiple myeloma
por: Deng, Cong, et al.
Publicado: (2021)

miR-539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion
por: Liu, Yanping, et al.
Publicado: (2017)

Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
por: Wang, Qiong, et al.
Publicado: (2022)

SYTL3–SLC22A3 Single-Nucleotide Polymorphisms and Gene–Gene/Environment Interactions on the Risk of Hyperlipidemia
por: Zheng, Peng-Fei, et al.
Publicado: (2021)

FSCN1 Promotes Glycolysis and Epithelial-Mesenchymal Transition in Prostate Cancer through a YAP/TAZ Signaling Pathway
por: Li, Minghui, et al.
Publicado: (2022)

Disulfiram Ophthalmic Solution Inhibited Macrophage Infiltration by Suppressing Macrophage Pseudopodia Formation in a Rat Corneal Alkali Burn Model
por: Ikebukuro, Toyo, et al.
Publicado: (2023)

FSCN1 promotes proliferation, invasion and glycolysis via the IRF4/AKT signaling pathway in oral squamous cell carcinoma
por: Li, Liang, et al.
Publicado: (2023)

Reverse Correlation between MicroRNA-145 and FSCN1 Affecting Gastric Cancer Migration and Invasion
por: Chen, Jia-jia, et al.
Publicado: (2015)

Measurement of number and cross-sectional area of basal cell pseudopodia: a new morphometric method
Publicado: (1981)

FSCN1 Promotes Radiation Resistance in Patients With PIK3CA Gene Alteration
por: Li, Sisi, et al.
Publicado: (2021)

Fscn1 is required for the trafficking of TGF-β family type I receptors during endoderm formation
por: Liu, Zhaoting, et al.
Publicado: (2016)

Significance of BMI1 and FSCN1 Expression in Colorectal Cancer
por: Alajez, Nehad M.
Publicado: (2016)

FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer
por: Wang, Chao-Qun, et al.
Publicado: (2017)

Retracted: FSCN1 Promotes Glycolysis and Epithelial-Mesenchymal Transition in Prostate Cancer through a YAP/TAZ Signaling Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

FSCN1 Promotes Esophageal Carcinoma Progression Through Downregulating PTK6 via its RNA-Binding Protein Effect
por: Cai, Hongfei, et al.
Publicado: (2022)

LYAR Promotes Colorectal Cancer Progression by Upregulating FSCN1 Expression and Fatty Acid Metabolism
por: Wu, Yupeng, et al.
Publicado: (2021)

Immune Signatures Combined With BRCA1-Associated Protein 1 Mutations Predict Prognosis and Immunotherapy Efficacy in Clear Cell Renal Cell Carcinoma
por: Gao, Ze, et al.
Publicado: (2021)

miR-145 Contributes to the Progression of Cervical Carcinoma by Directly Regulating FSCN1
por: Ma, Li, et al.
Publicado: (2019)

GADD45B Is a Potential Diagnostic and Therapeutic Target Gene in Chemotherapy-Resistant Prostate Cancer
por: Wang, Qiong, et al.
Publicado: (2021)

Transition to lanadelumab‐flyo from three medications for a hereditary angioedema patient with a variant in the SYTL2 gene: A case report
por: Burns, Stephanie, et al.
Publicado: (2021)

FSCN-1 increases doxorubicin resistance in hepatocellular carcinoma through promotion of epithelial-mesenchymal transition
por: Zhang, Yuanbiao, et al.
Publicado: (2018)

Purification of pseudopodia from polarized cells reveals redistribution and activation of Rac through assembly of a CAS/Crk scaffold
por: Cho, Samuel Y., et al.
Publicado: (2002)

Long noncoding RNA BSN-AS2 induced by E2F1 promotes spinal osteosarcoma progression by targeting miR-654-3p/SYTL2 axis
por: Zhou, Xianwei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tkpuieh43a2ld20ocod34g5mqj